Health ❯ Healthcare

Obesity

Treatment Options Weight Management Weight Loss Weight Loss Treatments Treatment Weight Loss Drugs Medications Obesity Treatment Obesity Management Health Risks

GLP‑1 Market Set to Balloon as Oral Pill Wins US Approval

US clearance of an oral GLP‑1 expands access while regulators and health systems confront supply strains, safety reports and care gaps.

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

CHMP Recommends Adding Oral Wegovy Tablets to EU Approval

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

New Analyses Find Weight-Loss Surgery Outperforms GLP-1 Drugs as Prescriptions Soar

Ashley Graham Condemns GLP-1 Weight-Loss Trend as a 'Smack in the Face'

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

Lancet Trial Finds Semaglutide Sharply Reduces Heavy Drinking in Patients With Obesity

New Risk Score Predicts 10-Year Risk for 18 Obesity-Linked Diseases

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

Amazon Rolls Out Nationwide GLP-1 Care Program Through One Medical

Genetic Clues Help Explain GLP‑1 Differences in Results

Kailera Leaps 62% in Nasdaq Debut After $625 Million IPO

UK Pharmacies Report Cloned Websites Pushing Fake Weight-Loss Jabs as Trade Body Urges Crackdown

UK Regulators Approve Single-Dose 7.2mg Wegovy Pen for Weekly Use

GLP-1 Pills Accelerate into U.S. Care with Amazon Rollout and New Evidence on Use and Response

France’s Weight-Loss Drug Boom Spurs Shortages, Safety Alerts, and a Shadow Market

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share